Osteochondral Lesion of Talus Clinical Trial
Official title:
Clinical Trial of the Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product With Microfracture for Osteochondral Lesion of Talus Patients
The purpose of this study is to evaluate the safety and efficacy of adding allogenic umbilical cord blood-derived stem cell product(Cartistem®) on currently standard treatment of arthroscopic curettage and microfracture for osteochondral lesion of talus.
same as above ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04475341 -
Osteochondral Lesions Under 15mm2 of the Talus; is Iliac Crest Bone Marrow Aspirate Concentrate the Key to Success?
|
N/A | |
| Enrolling by invitation |
NCT03856021 -
Microfracture vs. Microfracture and BMAC for Osteochondral Lesions of the Talus
|
N/A | |
| Not yet recruiting |
NCT05476692 -
Clinical Outcome of Surgical Treatment for Osteochondral Lesions of the Talus
|
||
| Active, not recruiting |
NCT02345564 -
Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery
|
N/A | |
| Active, not recruiting |
NCT01347892 -
DeNovo NT Ankle LDC Study
|
N/A | |
| Active, not recruiting |
NCT03750253 -
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
|
N/A | |
| Recruiting |
NCT06358807 -
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus
|
N/A | |
| Completed |
NCT04194970 -
Monitoring of Weight Bearing Protocols Via Mobile Application and Pressure Sensors.
|
N/A | |
| Withdrawn |
NCT05741983 -
AMIC vs. MFx in the Ankle
|
N/A | |
| Enrolling by invitation |
NCT04132076 -
Treatment Outcome After Ankle Joint Surgeries
|